Farther Finance Advisors’s TriSalus Life Sciences TLSI Stock Holding History
Bought
Maintained
Sold
Other funds holding TLSI
Farther Finance Advisors's TLSI Position: Q3 2026 in Review
Farther Finance Advisors increased its TriSalus Life Sciences (TLSI) stake by 2.6% in Q3 2026, buying an estimated $9 and bringing the position to 80 shares worth $345. The position accounts for ﹤0.01% of the portfolio, ranked #5806.
Farther Finance Advisors first reported a position in TLSI in Q1 2026 and has held it in 3 quarters since. The position peaked at $357 in Q2 2026. 2 funds tracked by Wall St. Rank hold TLSI as of Q3 2026.
- Farther Finance Advisors held 80 shares of TriSalus Life Sciences worth $345 as of Q3 2026.
- Farther Finance Advisors bought 2 TriSalus Life Sciences shares in Q3 2026, an estimated $9.
- TriSalus Life Sciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5806 holding.
- Farther Finance Advisors first reported a position in TriSalus Life Sciences in Q1 2026 and has held it in 3 quarters since.
- Farther Finance Advisors's TriSalus Life Sciences position peaked at $357 in Q2 2026.
- 2 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2026.
Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.